908 Devices Inc.
NASDAQ:MASSMedical - Devices
+$0.22 today
- Market cap
- $395.86M
- Beta
- 0.64
- P/E (TTM)
- -9.0
- EPS (TTM)
- -$0.97
Volume 0.25M
Average 0.27M
MASS Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
908 Devices Inc.NASDAQ: MASS
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $1.14M fell 11.8% year over year, behind the -7.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.5% from the prior quarter. Over 3 fiscal years it compounded at +33.4% a year.
Context
- Depreciation & amortization amounted to 6.8% of revenue in FY2025, down 1.0 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -11.8% toward the trailing-twelve-month pace of -7.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 3.83M USD
- Year-over-year change
- -18.2%
- 4-year CAGR
- +42.6%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.83M | -18.2% |
| FY2024 | 2024-12-31 | 4.68M | +96.4% |
| FY2023 | 2023-12-31 | 2.38M | +47.7% |
| FY2022 | 2022-12-31 | 1.61M | +74.5% |
| FY2021 | 2021-12-31 | 925K | — |
Depreciation & Amortization vs competitors
How MASS compares with its peers on the latest reported figures
- MASS's LTM Mar 2026 depreciation & amortization of $4.31M is the smallest of the 3 companies compared; the peer median is $236.56M.
- Its year-over-year change of -7.1% is the lowest of 3, against a peer median of +0.9%.
- Depreciation & amortization amounts to 7.5% of revenue for MASS, versus a peer median of 6.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $271M | -5.2% | -3.1% | 3.7% | |
| LTM Jun 2026 | $202.13M | +7.0% | -2.4% | 9.6% | |
| LTM Mar 2026 | $4.31M | -7.1% | +33.4% | 7.5% | |
| Peer median (excluding MASS) | $236.56M | +0.9% | -2.8% | 6.6% | |
Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (22.17M) | (33.56M) | (36.4M) | (72.21M) | 19.49M |
| Depreciation & Amortization | 925K | 1.61M | 2.38M | 4.68M | 3.83M |
| Deferred Income Tax | 0 | (129K) | (305K) | (283K) | 0 |
| Stock-Based Compensation | 2.5M | 7.21M | 9.79M | 11.76M | 9.85M |
| Change in Working Capital | (12.44M) | 3.36M | (1.57M) | (2.54M) | (15.3M) |
| Accounts Receivables | (11.28M) | 5.93M | 680K | (2.93M) | 220K |
| Inventory | (4.48M) | (5.48M) | (3.9M) | (1.66M) | (3.73M) |
| Accounts Payables | 2.75M | 0 | 0 | 0 | (5.93M) |
| Other Working Capital | 567K | 2.9M | 1.65M | 2.05M | (5.86M) |
| Other Non-Cash Items | 2.09M | 584K | 1.05M | 28.34M | (41.55M) |
| Operating Cash Flow | (29.08M) | (20.93M) | (25.06M) | (30.25M) | (23.69M) |
| Capital Expenditures | (737K) | (2.05M) | (2.05M) | (602K) | (955K) |
| Acquisitions (Net) | 0 | (13.76M) | 0 | (44.78M) | (2M) |
| Purchases of Investments | 0 | 0 | (48.87M) | (55.5M) | (64.01M) |
| Sales of Investments | 0 | 0 | 24.52M | 54.56M | 47.8M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 69.91M |
| Investing Cash Flow | (737K) | (15.81M) | (26.4M) | (46.32M) | 50.75M |
| Debt Repayment | (39K) | 0 | (15M) | 0 | 0 |
| Common Stock Issued | 852K | 1.55M | 936K | 1.15M | 864K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 93.91M | (374K) | (1.87M) | (1.52M) | (1.56M) |
| Financing Cash Flow | 94.73M | 1.18M | (15.94M) | (376K) | (697K) |
| Effect of Forex Changes | 0 | 18K | 13K | (65K) | 27K |
| Net Change in Cash | 64.91M | (35.54M) | (67.38M) | (77.01M) | 26.39M |
| Free Cash Flow | (29.82M) | (22.98M) | (27.1M) | (30.85M) | (24.64M) |
908 Devices Inc.
NASDAQ:MASS
Intrinsic Alpha fair value
Locked
Current Price
$9.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.